Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 65
Number of items: 65
  • Sarno, F., Koncz, M., Eilers, R. E., Verschure, P. J., & Rots, M. G. (2024). Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing. In A. Jeltsch, & M. G. Rots (Eds.), Epigenome Editing: Methods and Protocols (2nd ed., pp. 289-307). (Methods in molecular biology; Vol. 2842). Humana Press. https://doi.org/10.1007/978-1-0716-4051-7_15
  • Open Access
    Koncz, M., Lermo Jimenez, M. A., Piebes, D. G. E., Postma, M., & Verschure, P. J. (2024). Single-Molecule Analysis of Transcription Dynamics to Understand the Relationship Between Epigenetic Alterations and Transcriptional Variability. In A. Jeltsch, & M. G. Rots (Eds.), Epigenome Editing: Methods and Protocols (2nd ed., pp. 449-460). (Methods in molecular biology; Vol. 2842). Humana Press. https://doi.org/10.1007/978-1-0716-4051-7_23
  • Open Access
    van den Berg van Saparoea, A. C. H., van Loosen, Q. C., Sarno, F., Ntini, E., Rots, M. G., Gjaltema, R. A. F., & Verschure, P. J. (2024). Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing. In A. Jeltsch, & M. G. Rots (Eds.), Epigenome Editing: Methods and Protocols (2nd ed., pp. 255-265). (Methods in molecular biology; Vol. 2842). Humana Press. https://doi.org/10.1007/978-1-0716-4051-7_13
  • Open Access
    Jacob, J., van Loosen, Q. C., van den Berg van Saparoea, A. C. H., Sarno, F., & Verschure, P. J. (2024). Bridging bioengineering and epigenetics: from technical innovations to clinical applications. Epigenetics Communications, 4, Article 8. https://doi.org/10.1186/s43682-024-00031-x
  • Open Access
    Sarno, F., Goubert, D., Logie, E., Rutten, M. G. S., Koncz, M., Deben, C., Niemarkt, A. E., Altucci, L., Verschure, P. J., Kiss, A., vanden Berghe, W., & Rots, M. G. (2023). Functional Validation of the Putative Oncogenic Activity of PLAU. Biomedicines, 11(1), Article 102. https://doi.org/10.3390/biomedicines11010102
  • Open Access
    Beckman, W. F. (2021). The role of epigenetics in transcriptional stochasticity and the implications for breast cancer drug resistance. [Thesis, fully internal, Universiteit van Amsterdam].
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Springer Nature. https://doi.org/10.6084/m9.figshare.c.5067306.v1
  • Mandemaker, I. K., Zhou, D., Bruens, S. T., Dekkers, D. H., Verschure, P. J., Edupuganti, R. R., Meshorer, E., Demmers, J. A. A., & Marteijn, J. A. (2020). Histone H1 eviction by the histone chaperone SET reduces cell survival following DNA damage. Journal of Cell Science, 133, Article jcs235473. https://doi.org/10.1242/jcs.235473
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P., & Van Kampen, A. H. C. (2020). Additional file 7 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673830.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P., & Van Kampen, A. H. C. (2020). Additional file 4 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673821.v1
Page 1 of 7